Answers are grounded in this paper and cite their sources.
Anxiety disorders are common, distressing and impairing medical conditions that typically have an early onset and prolonged course, are associated with substantial comorbidity and result in increased use of health services. A range of psychological and pharmacological treatments for patients with anxiety disorders are widely available, but many patients who would be likely to benefit from intervention do not seek medical attention, and others who do present are not recognized by their doctors as having a potentially treatable condition. The overall care of many patients with anxiety disorders who are recognized and treated falls markedly below generally recommended standards. This review explores the many barriers to optimal pharmacological treatment of patients with anxiety disorders and suggests methods by which these obstacles might be overcome.
No takes yet. Share an insight, caveat, or question.
Baldwin et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: